Once-Weekly Oral Antipsychotic for Schizophrenia on the Horizon Once-Weekly Oral Antipsychotic for Schizophrenia on the Horizon

A novel, ultra-long-acting formulation of risperidone allowed once-weekly dosing, rapidly achieved therapeutic levels, and was safe and effective, results of a phase 2 trial show.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Psychiatry News Source Type: news